Generic Drug Injury Claims Not Preempted, 8th Circuit Rules
ST. LOUIS - Federal law does not preempt state court failure-to-warn claims against generic drug manufacturers, a panel of the Eighth Circuit U.S. Court of Appeals ruled Nov. 27, extending the U.S. Supreme Court’s preemption ruling in Wyeth v. Diana Levine (No. 06-1249, U.S. Sup.; 2009 U.S. LEXIS 1774) to generic drugs (Gladys Mensing v. Wyeth, Inc., et al., No. 08-3850, 8th Cir.).
Full story on lexis.com
Original post by LexisNexis® Mealey’sâ„¢ Legal News